Oculir

About:

Oculir develops non-invasive glucose meter that measures glucose from the conjunctiva of the eye.

Website: http://www.oculir.com

Top Investors: Canaan Partners, Three Arch Partners, ONSET Ventures, Shepherd Ventures, CHL Medical Partners

Description:

Oculir develops non-invasive glucose meter that measures glucose from the conjunctiva of the eye.

Total Funding Amount:

$7.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2003-01-01

Founders:

John Burd

Number of Employees:

1-10

Last Funding Date:

2005-12-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai